Meng-ting Tao

No. 601 Huangpu Avenue West, Tianhe District
Guangzhou, 510632, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Repurposing fusidic acid through colistin-mediated membrane permeabilization against Escherichia coli co-harboring mcr-1 and blaNDM-5.

Repurposing fusidic acid through colistin-mediated membrane permeabilization against Escherichia coli co-harboring mcr-1 and blaNDM-5.

Journal: Journal of applied microbiology

Published: October 07, 2025

Shikimic acid enhances vancomycin efficacy in experimental MRSA-induced infective endocarditis.

Shikimic acid enhances vancomycin efficacy in experimental MRSA-induced infective endocarditis.

Journal: The Journal of infection

Published: December 21, 2024

Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection.

Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection.

Journal: Frontiers in microbiology

Published: September 09, 2019

Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA.

Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA.

Journal: The Journal of antimicrobial chemotherapy

Published: December 13, 2017

In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model.

In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model.

Journal: Antimicrobial agents and chemotherapy

Published: June 21, 2017

Establishment of valnemulin susceptibility breakpoint against Clostridium perfringens in rabbits.

Establishment of valnemulin susceptibility breakpoint against Clostridium perfringens in rabbits.

Journal: Anaerobe

Published: March 01, 2017

In Vivo Pharmacokinetic and Pharmacodynamic Profiles of Antofloxacin against Klebsiella pneumoniae in a Neutropenic Murine Lung Infection Model.

In Vivo Pharmacokinetic and Pharmacodynamic Profiles of Antofloxacin against Klebsiella pneumoniae in a Neutropenic Murine Lung Infection Model.

Journal: Antimicrobial agents and chemotherapy

Published: December 21, 2016

Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.

Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.

Journal: The Journal of antimicrobial chemotherapy

Published: November 29, 2016

Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.

Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.

Journal: Anaerobe

Published: December 08, 2015

Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus.

Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus.

Journal: Frontiers in microbiology

Published: September 13, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026